Dyr726, a brain-penetrant inhibitor of PI3Kα, Type III receptor tyrosine kinases, and WNT signalling
Vasudha Tandon, Alessandra Fistrovich, Joaquina Nogales, Febe Ferro, Samantha Rokey, Carly R. Cabel, Amy Dunne Miller, Mary Yagel, Christina Duncan, Aditi Mandar Atmasidha, Ira Sharma, Gerrit Wilms, Karin Williams, Richard J. R. Elliott, Timothy Chavez, , Sourav Banerjee
This paper designs and evaluates Dyr726, a brain-penetrant multi-kinase inhibitor that targets PI3Kα, receptor tyrosine kinases, and WNT signaling, showing efficacy in preclinical cancer models.
bioRxiv · Mar 26, 2025 · PreprintCancer Biology